INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58,496,942 | -17.1% | 1,569,545 | -22.4% | 0.28% | -22.1% |
| Q4 2022 | $70,526,995 | -33.3% | 2,021,410 | +7.0% | 0.35% | -27.7% |
| Q3 2022 | $105,712,000 | -8.3% | 1,889,067 | -15.2% | 0.49% | -7.6% |
| Q2 2022 | $115,341,000 | -35.7% | 2,228,383 | -9.7% | 0.53% | -27.2% |
| Q1 2022 | $179,405,000 | -3.9% | 2,468,760 | +56.3% | 0.72% | +34.8% |
| Q4 2021 | $186,764,000 | +8.8% | 1,579,536 | +23.4% | 0.54% | +14.2% |
| Q3 2021 | $171,649,000 | +8.7% | 1,279,531 | +31.2% | 0.47% | -1.7% |
| Q2 2021 | $157,877,000 | – | 975,092 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |